Singapore markets closed

Aura Biosciences, Inc. (AURA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.34-0.03 (-0.41%)
As of 11:44AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-53,838
-76,408
-58,763
-35,251
-22,206
-
Depreciation & amortisation
1,084
1,295
1,177
831
831
-
Stock-based compensation
5,895
8,772
6,412
2,307
736
-
Change in working capital
-1,329
4,441
-3,846
-315
-3,679
-
Accounts payable
-515
-1,040
340
1,054
-1,721
-
Other working capital
-50,229
-64,556
-55,695
-34,535
-25,092
-
Other non-cash items
114
1,837
968
15
-3
-
Net cash provided by operating activities
-48,674
-63,847
-54,601
-32,410
-24,321
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,555
-709
-1,094
-2,125
-771
-
Purchases of investments
-174,005
-233,651
-119,784
0
-
-
Sales/maturities of investments
137,005
120,397
53,009
0
-
-
Net cash used for investing activities
-51,812
-113,963
-67,869
-2,125
-771
-
Cash flows from financing activities
Debt repayment
-
-
-
-
-34
-37
Common stock issued
-
3,170
8,549
78,697
0
-
Common stock repurchased
-
-
-
-
0
-13
Other financing activities
-
-
-
-15
-34
-
Net cash used provided by (used for) financing activities
80,572
97,290
95,629
166,259
10,036
-
Net change in cash
-19,914
-80,520
-26,841
131,724
-15,056
-
Cash at beginning of period
81,974
122,370
149,211
17,487
32,543
-
Cash at end of period
62,060
41,850
122,370
149,211
17,487
-
Free cash flow
Operating cash flow
-48,674
-63,847
-54,601
-32,410
-24,321
-
Capital expenditure
-1,555
-709
-1,094
-2,125
-771
-
Free cash flow
-50,229
-64,556
-55,695
-34,535
-25,092
-